This result is consistent with previous reports showing that increased Th1/Th17 pro-inflammatory cytokines (increased levels of TNF-α, IFN-γ, and IL-17A) and decreased Th2 anti-inflammatory function (decreased levels of IL-4) are responsible for promoting MS (44). The gene discussed is IL4; the disease is myeloid sarcoma.